EMERGENT BIOSOLUTIONS INC (EBS)
NYSE • Healthcare
Last close at August 10, 2026 at 20:00 UTC
Fundamentals Charts
About EMERGENT BIOSOLUTIONS INC
Emergent BioSolutions Inc. develops and supplies biodefense and public-health countermeasures in the healthcare and biotechnology field. Listed on the NYSE as EBS, it sells vaccines, therapeutics, medical countermeasures, and manufacturing services centered on U.S. government and health-security demand, and generated $742.9 million of revenue in FY2025.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
EMERGENT BIOSOLUTIONS INC's Technical Indicators Summary
EBS shows a clear technical breakdown with the stock trading below short, medium and long moving averages and under the lower Bollinger band, indicating price weakness; ADX around 38 signals a strong directional move to the downside. Momentum is mixed: extremely low RSI and stochastic readings point to oversold conditions while MACD and CCI remain negative, reinforcing bearish momentum. Volatility is elevated with ATR near 10% and OBV is deeply negative, suggesting weak volume support for any bounce. Technical takeaway: Strong Sell — pronounced downtrend, elevated volatility, and weak volume.
| Indicator | Value |
|---|---|
RSI (14) | 16.18 |
Stochastic %K (14, 3, 3) | 4.55 |
CCI (20) | -275.32 |
WPR (14) | -96.74 |
Momentum (10) | -2.86 |
MFI | 16.16 |
MACD Level (12, 26) | -0.65 |
Bollinger Bands | $5.13 - $9.07 |
ATR (14) | $0.47 (10.45%) |
ADX (14) | 38.01 |
OBV | -20,039,338 |
Classic Pivot Point | $5.07 |
Fibonacci Pivot Point | $5.07 |
Exponential Moving Averages | $6.26 - $8.93(5 indicators) |
Simple Moving Averages | $6.63 - $9.51(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
Bears took control in the last trading session, sending EBS down -7.64% by the close. EBS cut its FY2026 revenue forecast, signaling weaker near-term demand.
Trading Volume
Above 10d avg 1.6M
3.9M
vs S&P 500 Today
Strong Underperformance
-7.66%
52-Week Position
Near lows
1.1%
Updated: August 11, 2026 at 12:30 UTC